BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 2462074)

  • 1. CuI-catalyzed synthesis of multisubstituted pyrido[1,2-
    Mo B; Chen C; Peng J
    RSC Adv; 2023 Aug; 13(35):24264-24271. PubMed ID: 37583662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic strategies of heterocycle-integrated pyridopyrimidine scaffolds supported by nano-catalysts.
    Hammouda MM; Rashed MM; Elattar KM; Osman AMA
    RSC Adv; 2023 Apr; 13(17):11600-11634. PubMed ID: 37063723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient and environmentally sustainable domino protocol for the synthesis of structurally diverse spiroannulated pyrimidophenazines using erbium doped TiO
    Verma K; Tailor YK; Khandelwal S; Agarwal M; Rushell E; Kumari Y; Awasthi K; Kumar M
    RSC Adv; 2018 Aug; 8(53):30430-30440. PubMed ID: 35546857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient synthesis of new imidazo[1,2-
    Hosseini H; Bayat M
    RSC Adv; 2019 Mar; 9(13):7218-7227. PubMed ID: 35519992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.
    Khan I; Ibrar A; Zaib S
    Top Curr Chem (Cham); 2021 Jan; 379(1):3. PubMed ID: 33398642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How were new medicines discovered?
    Swinney DC; Anthony J
    Nat Rev Drug Discov; 2011 Jun; 10(7):507-19. PubMed ID: 21701501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro.
    Ito J; Asano K; Tryka E; Kanai K; Yamamoto S; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2000; 9(2):69-75. PubMed ID: 10958379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.
    Hasegawa T; Takagi K; Nadai M; Ogura Y; Nabeshima T
    Eur J Clin Pharmacol; 1994; 46(1):55-8. PubMed ID: 8005187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y; Kasai H; Kawashima T; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
    Yanagihara Y; Kasai H; Matsui S; Ninomiya K
    Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
    Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
    Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
    Yanagihara Y; Kasai H; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.